COMPANIES COVERED
GlaxoSmithKlineDownload FREE Report Sample
Download Free sampleAsthma is a type of chronic lung disease that inflames and narrows the airways. The symptoms of the disease are inclusive of recurring periods of wheezing, shortness of breath, chest tightness, and coughing. Asthma inhalers are the medical devices which deliver medication to the patient?s body via the lungs.
Asthma Inhaler Device Market contains market size and forecasts of Asthma Inhaler Device in global, including the following market information:
Global Asthma Inhaler Device Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Asthma Inhaler Device Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Asthma Inhaler Device companies in 2021 (%)
The global Asthma Inhaler Device market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Metered-Dose Inhaler Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Asthma Inhaler Device include GlaxoSmithKline, Merck & Co, 3M, Aristopharma, SRS PHARMACEUTICALS and Intas Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Asthma Inhaler Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Asthma Inhaler Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Asthma Inhaler Device Market Segment Percentages, by Type, 2021 (%)
Metered-Dose Inhaler
MDI with a Spacer
Dry-Powder Inhaler
Other
Global Asthma Inhaler Device Market, by Sale Channel, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Asthma Inhaler Device Market Segment Percentages, by Sale Channel, 2021 (%)
Hospital
Clinics
Retail Pharmacies
Other
Global Asthma Inhaler Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Asthma Inhaler Device Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Asthma Inhaler Device revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Asthma Inhaler Device revenues share in global market, 2021 (%)
Key companies Asthma Inhaler Device sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Asthma Inhaler Device sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Merck & Co
3M
Aristopharma
SRS PHARMACEUTICALS
Intas Pharmaceuticals
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy